In animal models of disease, iPSCs have been used to
treat sickle cell anemia, Parkinson's disease, diabetes, spinal cord injuries, and heart failure.
Sydney McLeod kept up her studies at Success Academy Charter Schools despite extensive absences to
treat her sickle cell anemia.
Emmaus Medical CEO Dr. Yutaka Niihara spent much of his career developing Endari, a recently approved FDA drug to
treat sickle cell anemia.
Not exact matches
So hold on tight, I'm gonna share EVERYTHING I've learned so far about cord blood with you... starting with this enlightening link on the general benefits... including the fact that «To date it can
treat more than 80 diseases using Haematopoietic Stem
Cell (HSC) transplants, including leukemia, sickle cell anemia, and metabolic disorders.&ra
Cell (HSC) transplants, including leukemia,
sickle cell anemia, and metabolic disorders.&ra
cell anemia, and metabolic disorders.»
In the early 1990s HemoTech was used in Zaire to successfully
treat nine children with
sickle -
cell anemia.
Patients with
sickle cell trait received about 13 % more of the medications used to
treat anemia than other patients to reach the same level of hemoglobin.
Gene editing techniques have the potential to
treat blood disorders that run in families, such as thalassemia and
sickle cell anemia, but their application has been largely limited to
cells in a laboratory and not living animals.
Along with
treating children with malignant disease, he also will care for those whose blood disorders are not malignant, such as patients with
sickle cell anemia.
Generally, a hematologist
treats patients with blood disorders, such as types of hemophilia, leukemia, lymphoma, and
sickle cell anemia.
Been diagnosed with, been
treated for or advised by a licensed member of the medical profession to receive treatment for Alzheimer's, dementia, memory loss, organic brain disease, mental incapacity, Lou Gehrig's disease (ALS), Down's Syndrome, Huntington's disease,
sickle cell anemia, cystic fibrosis, cerebral palsy or been diagnosed by a medical professional as having a terminal medical condition that is expected to result in death within the next 18 months?